Five-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Infarct-Related Artery

Hirofumi Ohashi1, Shoichi Kuramitsu2, Hiroaki Takashima1

  • 1Department of Cardiology, Aichi Medical University, Aichi, Japan.

Insights

Deferring revascularization in infarct-related artery lesions based on late fractional flow reserve (FFR) measurements after myocardial infarction (MI) is safe. Long-term outcomes showed no significant difference in target vessel failure between infarct-related and non-infarct-related lesions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • Limited long-term safety data exists for deferring revascularization guided by fractional flow reserve (FFR) in infarct-related artery (IRA) lesions post-myocardial infarction (MI).
  • FFR assessment in the late phase after MI requires further investigation for guiding treatment decisions.

Purpose of the Study:

  • To evaluate the long-term safety and outcomes of deferring revascularization in IRA lesions.
  • To assess the impact of late-phase FFR measurements on patient outcomes after MI.

Main Methods:

  • Utilized data from the J-CONFIRM registry, analyzing 1447 lesions (1263 patients) divided into IRA and non-IRA groups.
  • Primary endpoint was the 5-year cumulative incidence of target vessel failure (TVF), including cardiac death, target vessel-MI, and revascularization.
  • FFR was measured at a median of 716 days post-MI.

Main Results:

  • The infarct-related artery (IRA) group comprised 9.5% of lesions.
  • Visual-functional mismatches were similar between IRA and non-IRA groups (31.9% vs 36.3%).
  • The 5-year cumulative incidence of target vessel failure (TVF) was comparable between IRA (9.2%) and non-IRA (11.8%) groups, with no significant difference (p=0.71).

Conclusions:

  • Deferring revascularization guided by late-phase FFR in infarct-related artery lesions post-MI is associated with similar long-term outcomes compared to non-IRA lesions.
  • These findings support the use of FFR for deferring revascularization in IRA lesions, even in the late post-MI setting.
Abstract